ZC3H12D and in situ carcinoma: In order to calculate the sensitivity and specificity of TFL in the diagnosis of malignant laryngeal lesions, we divided our pathological results into two groups: 1) benign pathology results group, and 2) invasive carcinoma and CIS pathology results group.